35024177|t|Oxyphylla A ameliorates cognitive deficits and alleviates neuropathology via the Akt-GSK3beta and Nrf2-Keap1-HO-1 pathways in vitro and in vivo murine models of Alzheimer's disease.
35024177|a|Introduction: Alzheimer's disease (AD) is a progressive brain disorder, and one of the most common causes of dementia and amnesia. Due to the complex pathogenesis of AD, the underlying mechanisms remain unclear. Although scientists have made increasing efforts to develop drugs for AD, no effective therapeutic agents have been found. Objectives: Natural products and their constituents have shown promise for treating neurodegenerative diseases, including AD. Thus, in-depth study of medical plants, and the main active ingredients thereof against AD, is necessary to devise therapeutic agents. Methods: In this study, N2a/APP cells and SAMP8 mice were employed as in vitro and in vivo models of AD. Multiple molecular biological methods were used to investigate the potential therapeutic actions of oxyphylla A, and the underlying mechanisms. Results: Results showed that oxyphylla A, a novel compound extracted from Alpinia oxyphylla, could reduce the expression levels of amyloid precursor protein (APP) and amyloid beta (Abeta) proteins, and attenuate cognitive decline in SAMP8 mice. Further investigation of the underlying mechanisms showed that oxyphylla A exerted an antioxidative effect through the Akt-GSK3beta and Nrf2-Keap1-HO-1 pathways.Conclusions.Taken together, our results suggest a new horizon for the discovery of therapeutic agents for AD.
35024177	0	11	Oxyphylla A	Chemical	MESH:C000624958
35024177	24	42	cognitive deficits	Disease	MESH:D003072
35024177	58	72	neuropathology	Disease	MESH:D009422
35024177	81	84	Akt	Gene	11651
35024177	85	93	GSK3beta	Gene	56637
35024177	98	102	Nrf2	Gene	18024
35024177	103	108	Keap1	Gene	50868
35024177	109	113	HO-1	Gene	15368
35024177	144	150	murine	Species	10090
35024177	161	180	Alzheimer's disease	Disease	MESH:D000544
35024177	196	215	Alzheimer's disease	Disease	MESH:D000544
35024177	217	219	AD	Disease	MESH:D000544
35024177	238	252	brain disorder	Disease	MESH:D001927
35024177	291	299	dementia	Disease	MESH:D003704
35024177	304	311	amnesia	Disease	MESH:D000647
35024177	348	350	AD	Disease	MESH:D000544
35024177	464	466	AD	Disease	MESH:D000544
35024177	601	627	neurodegenerative diseases	Disease	MESH:D019636
35024177	639	641	AD	Disease	MESH:D000544
35024177	731	733	AD	Disease	MESH:D000544
35024177	802	805	N2a	CellLine	CVCL:0470
35024177	820	825	SAMP8	CellLine	CVCL:4564
35024177	826	830	mice	Species	10090
35024177	879	881	AD	Disease	MESH:D000544
35024177	983	994	oxyphylla A	Chemical	MESH:C000624958
35024177	1056	1067	oxyphylla A	Chemical	MESH:C000624958
35024177	1101	1118	Alpinia oxyphylla	Species	125261
35024177	1158	1183	amyloid precursor protein	Gene	11820
35024177	1208	1213	Abeta	Gene	11820
35024177	1239	1256	cognitive decline	Disease	MESH:D003072
35024177	1260	1265	SAMP8	CellLine	CVCL:4564
35024177	1266	1270	mice	Species	10090
35024177	1335	1346	oxyphylla A	Chemical	MESH:C000624958
35024177	1391	1394	Akt	Gene	11651
35024177	1395	1403	GSK3beta	Gene	56637
35024177	1408	1412	Nrf2	Gene	18024
35024177	1413	1418	Keap1	Gene	50868
35024177	1419	1423	HO-1	Gene	15368
35024177	1539	1541	AD	Disease	MESH:D000544
35024177	Negative_Correlation	MESH:C000624958	11820
35024177	Association	MESH:C000624958	18024
35024177	Association	MESH:C000624958	15368
35024177	Association	MESH:C000624958	11651
35024177	Association	MESH:C000624958	50868
35024177	Negative_Correlation	MESH:C000624958	MESH:D009422
35024177	Negative_Correlation	MESH:C000624958	MESH:D003072
35024177	Association	18024	50868
35024177	Association	15368	18024
35024177	Association	MESH:C000624958	56637
35024177	Association	11651	56637
35024177	Association	15368	50868

